1. Progranulin levels in blood in Alzheimer's disease and mild cognitive impairment
    Yonatan A. Cooper et al, 2018, Annals of Clinical and Translational Neurology CrossRef
  2. Fabrication and evaluation a transferrin receptor targeting nano-drug carrier for cerebral infarction treatment
    Junyi Shen et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
  3. Genistein inhibition of OGD-induced brain neuron death correlates with its modulation of apoptosis, voltage-gated potassium and sodium currents and glutamate signal pathway
    Xue-ling Ma et al, 2016, Chemico-Biological Interactions CrossRef
  4. Trichosanthis Pericarpium Aqueous Extract Protects H9c2 Cardiomyocytes from Hypoxia/Reoxygenation Injury by Regulating PI3K/Akt/NO Pathway
    Donghai Chu et al, 2018, Molecules CrossRef
  5. First-In-Human Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of AZP2006, A Synthetic Compound for the Treatment of Alzheimer’s Disease and Related Diseases
    Philippe Verwaerde et al, 2024, Journal of Alzheimer's Disease CrossRef
  6. Improving the protective effects of aFGF for peripheral nerve injury repair using sulfated chitooligosaccharides
    Yanmei Liu et al, 2019, Asian Journal of Pharmaceutical Sciences CrossRef
  7. Dexmedetomidine attenuates hypoxia/reoxygenation injury in primary neonatal rat cardiomyocytes
    Ke Peng et al, 2017, Experimental and Therapeutic Medicine CrossRef
  8. Progranulin in neurodegenerative dementia
    Xiao‐Ming Wang et al, 2021, Journal of Neurochemistry CrossRef
  9. Inflammatory markers in children and adolescents with type 2 diabetes mellitus
    Thomas Reinehr, 2019, Clinica Chimica Acta CrossRef
  10. Genetic Regulation of Neuronal Progranulin Reveals a Critical Role for the Autophagy-Lysosome Pathway
    Lisa P. Elia et al, 2019, The Journal of Neuroscience CrossRef
  11. Comparison of hypoxic effects induced by chemical and physical hypoxia on cardiomyocytes
    Ru-Zhou Zhao et al, 2019, Canadian Journal of Physiology and Pharmacology CrossRef
  12. Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population
    Thomas Reinehr et al, 2018, Current Diabetes Reports CrossRef
  13. Is there a link between progranulin, obesity, and parameters of the metabolic syndrome in children? Findings from a longitudinal intervention study
    Petra Niklowitz et al, 2019, Pediatric Diabetes CrossRef
  14. Involvement of progranulin (PGRN) in the pathogenesis and prognosis of breast cancer
    Daryush Purrahman et al, 2022, Cytokine CrossRef
  15. Microglial Progranulin: Involvement in Alzheimer’s Disease and Neurodegenerative Diseases
    Anarmaa Mendsaikhan et al, 2019, Cells CrossRef
  16. Progranulin concentration in relation to bone mineral density among obese individuals
    Alireza Milajerdi et al, 2018, Archives of Endocrinology and Metabolism CrossRef
  17. Coptisine protects cardiomyocyte against hypoxia/reoxygenation-induced damage via inhibition of autophagy
    Yahui Wang et al, 2017, Biochemical and Biophysical Research Communications CrossRef
  18. Alcohol extract of Rubia yunnanensis: Metabolic alterations and preventive effects against OGD/R‑induced oxidative damage in HT22 cells
    Jianghao Cheng et al, 2024, Biomedical Reports CrossRef